Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

The latest spat began after Altman joined Trump, SoftBank CEO Masayoshi Son, and Oracle Chairman Larry Ellison in a White House ceremony on Tuesday to announce the launch of Stargate, a $500 billion venture to advance the United States’ artificial intelligence infrastructure.

Elon Musk and OpenAI CEO Sam Altman are fighting on X about Stargate, the infrastructure project to build data centers for OpenAI in the U.S.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird for us in this one transition time."

US stocks were set for a steep selloff Monday morning after a surprise advancement from a Chinese artificial intelligence company, DeepSeek, threatened the aura of invincibility surrounding America’s technology industry.

It's Musk vs Altman - again. But look away from the griping and sniping and the more interesting developments relate to Microsoft and OpenAI redefining their partnership.

ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.